Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.

Radice A, Pieruzzi F, Trezzi B, Ghiggeri G, Napodano P, D'Amico M, Stellato T, Brugnano R, Ravera F, Rolla D, Pesce G, Giovenzana ME, Londrino F, Cantaluppi V, Pregnolato F, Volpi A, RombolĂ  G, Moroni G, Ortisi G, Sinico RA.

J Nephrol. 2018 Apr;31(2):271-278. doi: 10.1007/s40620-017-0451-5. Epub 2017 Oct 28.

PMID:
29081027
2.

Prevalence and clinical significance of early high Endotoxin Activity in septic shock: An observational study.

Bottiroli M, Monti G, Pinciroli R, Vecchi I, Terzi V, Ortisi G, Casella G, Fumagalli R.

J Crit Care. 2017 Oct;41:124-129. doi: 10.1016/j.jcrc.2017.04.030. Epub 2017 Apr 26.

PMID:
28525777
3.

Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).

Radice A, Trezzi B, Maggiore U, Pregnolato F, Stellato T, Napodano P, Rolla D, Pesce G, D'Amico M, Santoro D, Londrino F, Ravera F, Ortisi G, Sinico RA.

Autoimmun Rev. 2016 Feb;15(2):146-54. doi: 10.1016/j.autrev.2015.10.004. Epub 2015 Oct 23. Review.

PMID:
26527329
4.

Community-acquired Clostridium difficile infection in children: A retrospective study.

Borali E, Ortisi G, Moretti C, Stacul EF, Lipreri R, Gesu GP, De Giacomo C.

Dig Liver Dis. 2015 Oct;47(10):842-6. doi: 10.1016/j.dld.2015.06.002. Epub 2015 Jun 9.

PMID:
26141927
5.

Rhinoscleroma in an immigrant from Egypt: a case report.

Bonacina E, Chianura L, Sberna M, Ortisi G, Gelosa G, Citterio A, Gesu G, Puoti M.

J Travel Med. 2012 Dec;19(6):387-90. doi: 10.1111/j.1708-8305.2012.00659.x. Epub 2012 Oct 11.

6.

Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study.

Luzzaro F, Ortisi G, Larosa M, Drago M, Brigante G, Gesu G.

Diagn Microbiol Infect Dis. 2011 Apr;69(4):363-9. doi: 10.1016/j.diagmicrobio.2010.10.016.

PMID:
21396530
7.

Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients.

Nosari AM, Nador G, De Gasperi A, Ortisi G, Volonterio A, Cantoni S, Nichelatti M, Marbello L, Mazza E, Mancini V, Ravelli E, Ricci F, Ciapanna D, Garrone F, Gesu G, Morra E.

Leuk Lymphoma. 2008 Nov;49(11):2148-55. doi: 10.1080/10428190802409930.

PMID:
19021058
8.

Performance in detection and reporting beta-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories.

Luzzaro F, Gesu G, Endimiani A, Ortisi G, Malandrin S, Pagani L, Rossolini GM; Associazione Microbiologi Clinici Italiani (AMCLI) Committee for Antibiotics.

Diagn Microbiol Infect Dis. 2006 Aug;55(4):311-8. Epub 2006 May 6.

PMID:
16678993
9.

Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.

Jones ME, Gesu G, Ortisi G, Sahm DF, Critchley IA, Goglio A; Associazione Microbiologi Clinici Italiani (AMCLI) Committee for Antibiotics.

Clin Microbiol Infect. 2002 Feb;8(2):101-11.

10.

Infections in the surgical setting: epidemiology and effect of treatment with cefotaxime in a multicenter trial including 3,032 patients.

Privitera G, Auxilia F, Ortisi G, Matinato C, Castaldi S, Pagano A.

Am J Surg. 1992 Oct;164(4A Suppl):6S-11S.

PMID:
1443361
11.

Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery.

Privitera G, Scarpellini P, Ortisi G, Nicastro G, Nicolin R, de Lalla F.

Antimicrob Agents Chemother. 1991 Jan;35(1):208-10.

12.
13.

Effect of ofloxacin on human colonic microflora.

Ortisi G, Scarpellini P, Cernuschi M, Nicastro G, Moro M, Privitera G.

J Chemother. 1989 Jul;1(4 Suppl):613-5. No abstract available.

PMID:
16312556
14.

Impact of lenampicillin on the fecal flora of healthy volunteers.

Privitera G, Ortisi G, Scarpellini P, Nicastro G, Moro M, Cernuschi M.

J Chemother. 1989 Jul;1(4 Suppl):600-2. No abstract available.

PMID:
16312550
15.

Treatment of Clostridium difficile-associated disease with teicoplanin.

de Lalla F, Privitera G, Rinaldi E, Ortisi G, Santoro D, Rizzardini G.

Antimicrob Agents Chemother. 1989 Jul;33(7):1125-7.

16.

Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital.

de Lalla F, Privitera G, Ortisi G, Rizzardini G, Santoro D, Pagano A, Rinaldi E, Scarpellini P.

J Antimicrob Chemother. 1989 Apr;23(4):623-31.

PMID:
2663814
17.

Roxithromycin disposition in tonsils after single and repeated administrations.

Galioto GB, Ortisi G, Mevio E, Sassella D, Bartucci F, Privitera G.

Antimicrob Agents Chemother. 1988 Sep;32(9):1461-3.

18.

High homology of membrane proteins electrophoretic pattern in Bacteroides fragilis as confirmed by various solubilizing methods.

Costa A, Botta GA, Schito GC, Ortisi G, Privitera G, Menozzi MG.

Microbiologica. 1986 Jan;9(1):1-11.

PMID:
3951363
19.

[In vitro effects of cefotetan against Bacteroides of the fragilis group].

Privitera G, Ortisi G, Rossi R, Vigo B.

G Ital Chemioter. 1985 May-Aug;32(2):371-4. Italian. No abstract available.

PMID:
3869116
20.

Thiamphenicol in the prophylaxis and treatment of mixed infections of the female genital tract.

Moroni M, Mangioni C, Ortisi G, Marca G.

Sex Transm Dis. 1984 Oct-Dec;11(4 Suppl):444-8.

PMID:
6395379
21.

Randomized clinical trial of short-term antibiotic prophylaxis in 750 patients undergoing vaginal and abdominal hysterectomy.

Ferrari A, Baccolo M, Privitera G, Ortisi G, Sartor V, Gritti P, Bongetta R, Moroni M, Mangioni C.

Int Surg. 1984 Jan-Mar;69(1):21-7.

PMID:
6376404
22.

[Activity of josamycin against anaerobic bacteria].

Privitera G, Ortisi G, Bongetta R.

G Ital Chemioter. 1982;29 Suppl 1:39-44. Italian. No abstract available.

PMID:
6927120
23.

The colonization of Streptococcus faecium in human intestinal tract after oral administration.

Bongetta R, Quirino T, Ortisi G, Privitera G, Foschi D, Cavagna G, Moroni M, Rovati V.

Boll Ist Sieroter Milan. 1981 Nov;60(5):381-5.

PMID:
7340850
24.

[Antibiotic prophylaxis of mixed infections (aerobic-anaerobic) in gynecological surgery].

Moroni M, Ferrari N, Sartor V, Privitera G, Belloni C, Maggioni A, Ortisi G.

G Ital Chemioter. 1979 Jan-Dec;26(1-2):349-56. Italian. No abstract available.

PMID:
400148

Supplemental Content

Loading ...
Support Center